Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Foster vs Symbicort in COPD (FAIR)
NCT01351792Phase 3Terminated
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2011
- Primary completion
- Nov 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of beclometasone dipropionate + formoterol in chronic obstructive pulmonary disease (COPD), sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2011; status: terminated.
02
Drugs
beclometasone dipropionate + formoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT01351792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01351792.